LATAM OTC Results Round-Up: Mexico's Genomma Lab, Brazil's Hypera
Executive Summary
Genomma enjoys broad-based growth in 2018, while NPD investments pay off for Hypera.
You may also be interested in...
Sanofi Partners With Colombian Tech Firm Rappi To 'Transform' Healthcare In Latin America
Sanofi Consumer Healthcare is utilizing emerging digital technology to take a bigger slice of the Latin American OTC market. Through a partnership deal, e-commerce and delivery firm Rappi will promote and sell Sanofi's brands to consumers across seven Latin American markets.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.
Sweden Seeks To Tackle Opioid Overdose Deaths With Naloxone Rx-To-OTC Switch
Opioid antagonist naloxone will soon be available without prescription in Sweden following a successful Rx-to-OTC application from Norway's DNE Pharma.